During August 4-8, Shenzhen Microprofit Biotech Co., Ltd participated in the 71stAACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, California, USA. AACC Clinical Lab Expo featured 835 exhibitors this year, which is the highest number of exhibitors in AACC’s history. This dynamic exhibit featured groundbreaking tests from all laboratory medicine disciplines, including mobile health, molecular diagnostics, mass spectrometry, point of care, and automation.

As a continuous cultivator and solution provider in POCT field, Microprofit Biotech attended the Clinical Lab Expo this year at booth No.3512, Anaheim Convention Center and displayed main products for in-vitro diagnosis based on our Immunofluorescence Quantitative Platform.

 

The official brand of Microprofit Biotech, fluorecare®, provides various kinds of POCT parameters including tumor markers, hormone markers, infection markers, cardiac markers and diabetes markers with our Dry-type Immunofluorescence Quantitative platform. With few easy steps, result of certain test item would be accurately measured and calculated.They are ideal supporting products especially for community hospitals and primary clinics.

Our analyzer and test products of fluorecare have drawn much attention of visitors and customers. It is our great pleasure to meet everyone here and we feel extremely honored to introduce our products to you. The 71st AACC annual scientific meeting & Clinical Lab Expo has officially and successfully completed. We would like to thank everyone who visited our booth.

 

We will also participate in the MEDICA 2019 in the coming November this year at Düsseldorf, Germany. Microprofit Biotech will display our new products and whole POCT solution. We are looking forward to meet you there!